✦ LIBER ✦

6096 Frequency of KRAS/BRAF mutations as predictive markers for Cetuximab in Japanese colorectal cancer patients

✍ Scribed by Yokota, T.; Shibata, N.; Ura, T.; Takahari, D.; Shitara, K.; Muro, K.; Yatabe, Y.

Book ID: 123058447
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71191-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical usefulness ofKRAS,BRAF, andPIK3

Clinical usefulness ofKRAS,BRAF, andPIK3CAmutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

✍ Soeda, Hiroshi; Shimodaira, Hideki; Watanabe, Mika; Suzuki, Takao; Gamoh, Makio; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 402 KB

KRAS Mutations As an Independent Prognos

KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

✍ Lievre, A.; Bachet, J.-B.; Boige, V.; Cayre, A.; Le Corre, D.; Buc, E.; Ychou, M 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 148 KB

Quantitative Cell-Free DNA, KRAS, and BR

Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan

✍ Spindler, K.-L. G.; Pallisgaard, N.; Vogelius, I.; Jakobsen, A. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

Predictive and prognostic value of KRAS

Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies

✍ Li-Xin Qiu; Chen Mao; Jian Zhang; Xiao-Dong Zhu; Ru-Yan Liao; Kai Xue; Jin Li; Q 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 154 KB

6113 BRAF V600E mutation and Amphireguli

6113 BRAF V600E mutation and Amphiregulin (AR) immunohistochemical expression in the prediction of benefit from cetuximab plus irinotecan in KRAS wild-type metastatic colorectal cancer (mCRC) patients

✍ Cremolini, C.; Loupakis, F.; Perrone, G.; Ruzzo, A.; Rulli, E.; Bencardino, K.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

6014 POSTER DISCUSSION Cetuximab Treatme

6014 POSTER DISCUSSION Cetuximab Treatment for Metastatic Colorectal Cancer With KRAS p.G13D Mutation may Improve Progression-free Survival in Japanese Patients

✍ Osako, M.; Kawazoe, Y.; Mizunuma, N.; Gotoh, T.; Misaka, T.; Oba, M.; Shinozaki, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB